[STARTUPS]■ STORY TIMELINE
ENVEDA LANDS $311M FOR NATURE-BASED AI DRUG TRIALS
Enveda Therapeutics raised $311 million in funding, bringing the AI biotech company's valuation to $2 billion. The capital will accelerate clinical trials for drugs derived from natural compounds.
TechCrunch+0m
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve wei…